InvestorsHub Logo
Followers 17
Posts 936
Boards Moderated 0
Alias Born 04/26/2010

Re: frrol post# 251555

Monday, 12/17/2018 11:16:38 AM

Monday, December 17, 2018 11:16:38 AM

Post# of 403025
Yup. Have to admit a defeat on prurisol. It would be educational to see their further analysis. I doubt that we will.

Mildy pleasant surprise with B-OM, thou. FDA allowed both cisplatin schedules, Q1W and Q3W. I was expecting Q3W only. Somebody must have done nice job explaining in EOP2 meeting.

Now it is purely question of money. A P3 trial will probably need headcount around 200 subjects or so. At least that's what soligenix is doing. Cost probably $30M or more. From where and when?

"I would rather have questions that can't be answered than answers that can't be questioned." Richard P. Feynman

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News